Our US Grantees


Jeroen Roose, Ph.D.

University of California San FranciscoTherapeutic targeting of the oncogenic Ras pathway in T cell leukemia...more

yu division

Jianhua Yu, PhD

Assistant Professor (Tenure-Track) The Ohio State University Specific Targeting of the Leukemia-Associated Antigen FLT3 Using Chimeric Antigen Receptor (CAR)-Engineered NK...more

jianjun chen

Jianjun Chen, Ph.D.

The University of Chicago The role and targets of APL-specific miRNAs in leukemogenesis...more

john gerecitano

John F. Gerecitano, M.D., Ph.D.

Memorial Sloan-Kettering Cancer Center Targeting DNA Repair mechanisms and Tumor Protein Regulation to Treat Patients with Lymphoma...more

john m timmerman

John M. Timmerman, M.D.

University of California, Los Angeles Anti-CTLA Monoclonal Antibody Therapy for B Cell Lymphoma...more

johnathan schatz

Jonathan H. Schatz, M.D.

Memorial Sloan-Kettering Cancer Center Genomics of Peripheral T-Cell Lymphoma...more

julia glade bender

Julia L. Glade-Bender, M.D.

New York Presbyterian/Columbia A Pilot Study of Investigating the Effects of Glutamine and Vincristine-induced Neuropathy in Pediatric Patients with Cancer...more

juliet barker

Juliet N. Barker, MBBS (Hons), FRACP

Memorial Sloan-Kettering Cancer Center Double Unit Grafts for the Treatment of High Risk Hematologic Malignancies...more

kala visvanathan

Kala Visvanathan, MB, BS, FRACP, MHS

Johns Hopkins University, Bloomberg School of Public Health Modulation of Estrogen Metabolites by Broccoli Sprouts: Novel Intermediate Markers for Chemoprevention...more

kara scheibner

Kara A. Scheibner, Ph.D.

University of Maryland School of Medicine miR-23a cluster and miR-10a regulation of self-renewal and survival pathways in human hematopoietic stem-progenitor...more

karen popkin

Karen E. Popkin, LCAT, HPMT, MT-BC

Memorial Sloan-Kettering Cancer Center Gabrielle's Music Therapy Program...more

kristen ness

Kirsten Ness, P.T., Ph.D.

St. Jude Children's Research Hospital Vibration Intervention for Bone Enhancement in Childhood Cancer Survivors...more

Louie Naumovski, M.D.

Stanford University School of Medicine Chemo resistance to Phase I/II Anti-cancer Agents...more

l wartman

Lukas D. Wartman, MD

Assistant Professor of Medicine Washington University St. Louis Integrative Epigenomics: The Consequences of Kdm6a Inactivation on Chromatin Accessibility and DNA...more

maus marcela

Marcela V. Maus, MD, PhD

Massachusetts General HospitalIdentification and correction of T cell defects in patients with chronic lymphocytic leukemia and impact on T cell therapy....more

marcello rotta

Marcello Rotta

Fred Hutchinson Cancer Research Center New approaches to Haploidentical Hemopoietic Cell Transplant...more

martin caroll

Martin Carroll, M.D.

University of Pennsylvania Medical Center Activation of Signal Transduction Pathways in Leukemia...more


Matthew J. Walter, M.D.

Washington University, St. Louis Dynamic Changes in MDS Clonal Architecture During Treatment with Hypomethylating Agents...more

michael major

Michael B. Major, PhD

Assistant Professor Molecular Rationale for WNT Inhibitor Therapy in B-Cell LymphomaUNC Lineberger...more

Nigel Killeen, Ph.D.

University of California, San Francisco The Development of Murine Models of Recurring Myeloid Leukemia-Associated Chromosomal Deficiencies...more